Wuhan Xiangfang Specialty Clinical Pharmacology Research Center

Wuhan Xiangfang Specialty Clinical Pharmacology Research Center is a specialized contract research organization (CRO) based in Wuhan, China, focusing on early-phase clinical drug development. Founded in 2003, the center provides a comprehensive range of services including Phase I clinical trials, bioequivalence (BE) studies, and pharmacokinetic/pharmacodynamic (PK/PD) evaluations. It operates dedicated clinical trial facilities and bioanalytical laboratories that adhere to international Good Clinical Practice (GCP) standards. The organization serves as a critical partner for pharmaceutical companies seeking regulatory approval for both innovative drugs and generic formulations in the Chinese market. Its expertise extends across various therapeutic modalities, including small molecules and biologics.